DURECT Corp - ESG Rating & Company Profile powered by AI
This report of DURECT Corp is assembled by All Street Sevva using advanced NLP. The ESG score covers seventeen UN SDGs including: 'Clean Water & Sanitation', 'Climate Action' and 'Peace, Justice & Strong Institutions'. Alternative companies in the scoring industry group for DURECT Corp are shownin the table.
DURECT Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 1.6, social score of 6.4 and governance score of 6.7.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 999 | Xeris Pharmaceuticals Inc | 5.1 | High |
| 999 | Vascular Biogenics Ltd | 5.1 | High |
| 1047 | DURECT Corp | 5.0 | High |
| 1047 | Anixa Biosciences Inc | 5.0 | High |
| 1047 | Amarin Corporation PLC | 5.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does DURECT Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes DURECT Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes DURECT Corp report the average age of the workforce?
Sign up for free to unlockDoes DURECT Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes DURECT Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes DURECT Corp disclose cybersecurity risks?
Sign up for free to unlockDoes DURECT Corp offer flexible work?
Sign up for free to unlockDoes DURECT Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes DURECT Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes DURECT Corp conduct supply chain audits?
Sign up for free to unlockDoes DURECT Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes DURECT Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes DURECT Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes DURECT Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes DURECT Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes DURECT Corp disclose water use targets?
Sign up for free to unlockDoes DURECT Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid DURECT Corp have a product recall in the last two years?
Sign up for free to unlockDoes DURECT Corp disclose incidents of discrimination?
Sign up for free to unlockDoes DURECT Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas DURECT Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes DURECT Corp disclose parental leave metrics?
Sign up for free to unlockDoes DURECT Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes DURECT Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes DURECT Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes DURECT Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes DURECT Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes DURECT Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs DURECT Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes DURECT Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes DURECT Corp disclose its waste policy?
Sign up for free to unlockDoes DURECT Corp report according to TCFD requirements?
Sign up for free to unlockDoes DURECT Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes DURECT Corp disclose energy use targets?
Sign up for free to unlockDoes DURECT Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes DURECT Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for DURECT Corp
These potential risks are based on the size, segment and geographies of the company.
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.